Zura Bio Limited

NASDAQ: ZURA
Share price (12/20/24): $2.28
Market cap (12/20/24): $149 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1 2024 – amended

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Shelf registration – amended

Shelf registration – amended

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Shelf registration

Ownership Filter

Jarrett Jennifer

Graham Neil Murray Hamilton

Ploos Van Amstel Arnout

Schoch Steven J

Kulkarni Sandeep Chidambar

News Filter

Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

To Present at the Piper Sandler 36th Annual Healthcare Conference

Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults With Systemic Sclerosis

Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Conference Details

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness